| breast cancer - triple negative | |||
| mBC - Triple negative (TNBC) - 1st Line (L1) | la/mBC - TNBC - L2 - all population | la/mBC - TNBC - L2 - PDL1 positive | |
| non platinum-based chemotherapy | |||
| nucleoside analogues (pyrimidine/purine) | |||
| gemcitabine | IMpassion-132 ... IMpassion-132 ... | IMpassion-132 ... IMpassion-132 ... | |
| taxanes | |||
| paclitaxel | |||
| nab-paclitaxel | FUTURE-SUPER_immunomodulatory subtype | ||
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
